Hypertriglyceridemia associated with anticancer therapy based on asparaginase and steroids: a retrospective single center study of children with acute lymphoblastic leukemia and lymphoblastic lymphoma

Anna Małecka, Marcin Hennig, Ninela Irga-Jaworska

Vol 54, No 4 (2023)

Original research article

Treatment of primary central nervous system lymphoma (PCNSL) – single center experience.

Justyna Rybka, Bartłomiej Kuszczak, Aleksandra Bogucka-Fedorczuk

Vol 55, No 3 (2024)

Original research article

Asciminib a new player in treatment of TKI-resistant/intolerant chronic phase chronic myelogenous leukemia

Krzysztof Lewandowski

Vol 55, No 2 (2024)

Review article

Sclerodermatous manifestation of chronic graft versus host disease: therapy challenges

Monika Richert-Przygońska, Magdalena Milewska, Robert Dębski, Joanna Cisek, Krzysztof Czyżewski

Vol 54, No 5 (2023)

Original research article

Current knowledge and management of primary mediastinal large B-cell lymphoma

Sylwia Szydłowska, Lidia Gil, Grzegorz Dworacki, Andrzej Balcerzak

Vol 55, No 3 (2024)

Review article

Pathogenesis of hematological parameters in hypertension

Saira Rafaqat, Ayesha Zafar, Hunaiza Tahir, Huma Khurshid, Sana Rafaqat

Vol 54, No 6 (2023)

Review article

Is urinary type IV collagen a good marker of early impairment of renal function in childhood cancers survivors?

Michalina Jezierska, Anna Owczarzak, Joanna Stefanowicz

Vol 54, No 4 (2023)

Original research article

Diagnostic and therapeutic challenges of ALK-positive anaplastic large cell lymphoma: case report and literature review

Agnieszka Brzezińska, Aneta Szudy- Szczyrek, Daria Majowicz- Kostrzewa, Dorota Koczkodaj, Agata Filip, Marek Hus, Tomasz Gromek, Sylwia Chocholska

Vol 55, No 5 (2024)

Review article

Safe use of fecal microbiota transplant in treatment of graft versus host disease in a 5-year-old child

Anna Izabela Fałkowska, Adam Jakubas, Laura Surdacka, Jakub Jagiełło, Katarzyna Drabko, Agnieszka Zaucha-Prażmo

Vol 54, No 4 (2023)

Clinical vignette

The impact of CAR-T therapy for outcomes in primary refractory acute lymphoblastic leukemia

Joanna Stankiewicz, Ewa Demidowicz, Natalia Bartoszewicz, Andrzej Kołtan, Monika Richert-Przygońska, Jan Styczyński

Vol 54, No 4 (2023)

Short communication

Expert opinion on use of acalabrutinib for chronic lymphocytic leukemia treatment

Bartosz Puła, Elżbieta Iskierka-Jażdżewska, Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wróbel, Tadeusz Robak, Iwona Hus

Vol 55, No 3 (2024)

Guidelines / Expert consensus

Secondary resistance to imatinib in child with chronic myeloid leukemia as result of mutations in BCR ABL-1 kinase domain

Katarzyna Martyna Pawelec, Katarzyna Albrecht

Vol 54, No 4 (2023)

Clinical vignette

Metabolic profile analysis in hematological malignancies

Piotr Halicki, Klaudia Cieśluk, Jarosław Piszcz

Vol 55, No 1 (2024)

Review article

Identifying frailty in older people living with diffuse large B-cell lymphoma: a systematic review

Teodoro J. Oscanoa, Roman Romero-Ortuno

Vol 54, No 6 (2023)

Review article

Update on management of diffuse large B-cell lymphoma Richter's transformation

Oktawia Sośnia, Bartosz Puła

Vol 55, No 2 (2024)

Review article